Guardant Health, Inc.

Exact Sciences Corp. announced today encouraging data from an ongoing colorectal cancer trial showing that its blood-based test can detect advanced precancerous lesions and growing tumors. The findin

Guardant Health, Inc. said its Shield blood test is the first blood test approved by the US Food and Drug Administration (FDA) as a primary screening option for colorectal cancer and the first such t

FDA Panel Strongly Recommends Approval Of Colon Cancer Blood Test The Guardant Health, Inc. Shield, which screens the blood for markers of colon and rectal cancers, got the thumbs up from a US Food

The lung cancer therapeutic space is fast-paced and hopeful, with new therapies approved for gene mutations allowing for personalized medicine and an evolving understanding of disease biology. And dyn